The study of the full spectrum of variants leading to hyperphenylalaninemia have revealed 10 new variants in the PAH gene
- 127 Downloads
This study presents further research into the spectrum of variants in genes responsible for the development of phenylketonuria (PKU) and hyperphenylalaninemia (HPA) in patients in Russia. After a study of 25 frequent variants, 293 patients (327 chromosomes without detected variants) from among 1265 probands still had no confirmed diagnosis. A study involving methods of next generation sequencing (NGS) of PAH, PTS, GCH1, PCBD1, QDPR, SPR and DNAJC12 genes to search for point mutations and multiplex ligation-dependent probe amplification (MLPA) methods to search for gross deletions were conducted for these patients. Among 327 chromosomes without identified variants, variants in the PAH gene were found on 260 chromosomes, and variants in the PTS gene were found on 10 chromosomes. On 10 chromosomes gross deletions by the MLPA method were detected. 104 rare variants of the РАН gene, including 10 variants not previously described, and 6 variants of the PTS gene were revealed. The NGS method revealed additional РАН gene variants on 10.3% of chromosomes and PTS gene variants on 0.4%. Gross deletions of the РАН gene were revealed in 0.5% of chromosomes. Thus, the most complete understanding of the spectrum of variants leading to the development of the PKU and HPA in Russia with the use of all methods available today has been obtained. Such a detailed study of the spectrum of rare variants on the genetic material from Russia was undertaken for the first time.
KeywordsNext generation sequencing Tetrahydrobiopterin Phenylketonuria Hyperphenylalaninemia
The authors are grateful for the participation of all patients in this study. We would like to thank clinical genetic specialists from all over the country for their cooperation.
The research was carried out within the state assignment of Ministry of Science and Higher Education of the Russian Federation.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
- Anikster Y, Haack TB, Vilboux T, Pode-Shakked B, Thöny B, Shen N, Guarani V, Meissner T, Mayatepek E, Trefz FK, Marek-Yagel D, Martinez A, Huttlin EL, Paulo JA, Berutti R, Benoist JF, Imbard A, Dorboz I, Heimer G, Landau Y, Ziv-Strasser L, Malicdan MCV, Gemperle-Britschgi C, Cremer K, Engels H, Meili D, Keller I, Bruggmann R, Strom TM, Meitinger T, Mullikin JC, Schwartz G, Ben-Zeev B, Gahl WA, Harper JW, Blau N, Hoffmann GF, Prokisch H, Opladen T, Schiff M (2017) Biallelic mutations in DNAJC12 cause Hyperphenylalaninemia, dystonia, and intellectual disability. Am J Hum Genet 100:257–266. https://doi.org/10.1016/j.ajhg.2017.01.002 CrossRefPubMedPubMedCentralGoogle Scholar
- BIOPKU (2006-2019) http://www.biopku.org
- Bonafe L, Thony B, Penzien JM, Czarnecki B, Blau N (2001) Mutations in the sepiapterin reductase gene cause a novel tetrahydrobiopterin-dependent monoamine-neurotransmitter deficiency without hyperphenylalaninemia. Am J Hum Genet 69:269–277. https://doi.org/10.1086/321970 CrossRefPubMedPubMedCentralGoogle Scholar
- Chiu YH, Chang YC, Chang YH, Niu DM, Yang YL, Ye J, Jiang J, Okano Y, Lee DH, Pangkanon S, Kuptanon C, Hock NL, Chiong MA, Cavan BV, Hsiao KJ, Liu TT (2012) Mutation spectrum of and founder effects affecting the PTS gene in east Asian populations. J Hum Genet 57:145–152. https://doi.org/10.1038/jhg.2011.146 CrossRefPubMedGoogle Scholar
- Jeannesson-Thivisol E, Feillet F, Chéry C, Perrin P, Battaglia-Hsu SF, Herbeth B, Cano A, Barth M, Fouilhoux A, Mention K, Labarthe F, Arnoux JB, Maillot F, Lenaerts C, Dumesnil C, Wagner K, Terral D, Broué P, de Parscau L, Gay C, Kuster A, Bédu A, Besson G, Lamireau D, Odent S, Masurel A, Guéant JL, Namour F (2015) Genotype-phenotype associations in French patients with phenylketonuria and importance of genotype for full assessment of tetrahydrobiopterin responsiveness. Orphanet J Rare Dis 10:158. https://doi.org/10.1186/s13023-015-0375-x CrossRefPubMedPubMedCentralGoogle Scholar
- Li N, Jia H, Liu Z, Tao J, Chen S, Li X, Deng Y, Jin X, Song J, Zhang L, Liang Y, Wang W, Zhu J (2015) Molecular characterisation of phenylketonuria in a Chinese mainland population using next-generation sequencing. Sci Rep 5:15769. https://doi.org/10.1038/srep15769 CrossRefPubMedPubMedCentralGoogle Scholar
- Richards S et al (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17:405–424. https://doi.org/10.1038/gim.2015.30 CrossRefPubMedPubMedCentralGoogle Scholar
- Stepanova AA, Polyakov AV, Tverskaya SM (2006) Molekulyarno-geneticheskoye issledovaniye genov tetrogidrobiopterinovogo obmena QDPR i PTS v gruppe rossiyskikh bol'nykh fenilketonuriyey [in russ]. Med Genet 9:3–8Google Scholar
- Thony B et al (1998) Hyperphenylalaninemia with high levels of 7-biopterin is associated with mutations in the PCBD gene encoding the bifunctional protein pterin-4a-carbinolamine dehydratase and transcriptional coactivator (DCoH). Am J Hum Genet 62:1302–1311. https://doi.org/10.1086/301887 CrossRefPubMedPubMedCentralGoogle Scholar
- Trujillano D, Perez B, González J, Tornador C, Navarrete R, Escaramis G, Ossowski S, Armengol L, Cornejo V, Desviat LR, Ugarte M, Estivill X (2014) Accurate molecular diagnosis of phenylketonuria and tetrahydrobiopterin-deficient hyperphenylalaninemias using high-throughput targeted sequencing. Eur J Hum Genet 22:528–534. https://doi.org/10.1038/ejhg.2013.175 CrossRefPubMedGoogle Scholar
- van Wegberg AMJ, MacDonald A, Ahring K, Bélanger-Quintana A, Blau N, Bosch AM, Burlina A, Campistol J, Feillet F, Giżewska M, Huijbregts SC, Kearney S, Leuzzi V, Maillot F, Muntau AC, van Rijn M, Trefz F, Walter JH, van Spronsen FJ (2017) The complete European guidelines on phenylketonuria: diagnosis and treatment. Orphanet J Rare Dis 12:162. https://doi.org/10.1186/s13023-017-0685-2 CrossRefPubMedPubMedCentralGoogle Scholar
- Wang R, Shen N, Ye J, Han L, Qiu W, Zhang H, Liang L, Sun Y, Fan Y, Wang L, Wang Y, Gong Z, Liu H, Wang J, Yan H, Blau N, Gu X, Yu Y (2018) Mutation spectrum of hyperphenylalaninemia candidate genes and the genotype-phenotype correlation in the Chinese population. Clin Chim Acta 481:132–138. https://doi.org/10.1016/j.cca.2018.02.035 CrossRefPubMedGoogle Scholar
- Zekanowski C, Nowacka M, Sendecka E, Sowik M, Cabalska B, Bal J (1998) Identification of mutations causing 6-Pyruvoyl- tetrahydrobiopterin synthase deficiency in polish patients with variant Hyperphenylalaninemia. Mol Diagn 3:237–239 https://doi.org/10.1016/S1084-8592(98)80047-7 CrossRefGoogle Scholar